Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Find the latest Diffusion Pharmaceuticals Inc. (DFFN) stock quote, history, news and other vital information to help you with your stock trading and investing. One share of DFFN stock can currently be purchased for approximately $0.84.Diffusion Pharmaceuticals has a market capitalization of $53.44 million. Export data to Excel for your own analysis. The 5G technology revolution has now arrived. All users should speak with their financial advisor before buying or selling any securities. View which stocks are hot on social media with MarketBeat's trending stocks report.Identify stocks that meet your criteria using seven unique stock screeners. Sign-up to receive the latest news and ratings for DFFN and its competitors with MarketBeat's FREE daily newsletter.Diffusion Pharmaceuticals' stock was trading at $0.3434 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Its lead product candidate is transcrocetinate sodium, which is in Phase III trials for the treatment of glioblastoma multiforme (GBM); Phase II clinical trials for the treatment of pancreatic cancer and metastatic brain cancer; and Phase II trial for the treatment of acute stroke. Shares of DFFN can be purchased through any online brokerage account. Some companies that are related to Diffusion Pharmaceuticals include Based on aggregate information from My MarketBeat watchlists, some companies that other Diffusion Pharmaceuticals investors own include Diffusion Pharmaceuticals trades on the NASDAQ under the ticker symbol "DFFN. Want to see which stocks are moving? "Diffusion Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Diffusion Pharmaceuticals Inc (DFFN:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Diffusion Pharmaceuticals Inc Stock Forecast, "DFFN" Stock Predictons by days: 2021 Get Our PREMIUM Forecast Now, from ONLY $5.99! Their forecasts range from $3.50 to $3.50. All rights reserved.
Since then, DFFN stock has increased by 143.2% and is now trading at $0.8351. © American Consumer News, LLC dba MarketBeat® 2010-2020. Diffusion Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, November 9th 2020. Learn everything you need to know about successful options trading with this three-part video course.Looking for new stock ideas? Your losses are our losses too. At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Diffusion Pharmaceuticals, Inc.. Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company.
An investor that had 100 shares of Diffusion Pharmaceuticals stock prior to the reverse split would have 7 shares after the split. 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Diffusion Pharmaceuticals in the last year. On average, they expect Diffusion Pharmaceuticals' stock price to reach $3.50 in the next year. © 2020 Market data provided is at least 10-minutes delayed and hosted by This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk".
Here are the most read:All markets data located on FT.com is subject to the All content on FT.com is for your general information and use only and is not intended to address your particular requirements. The consensus among analysts is that Diffusion Pharmaceuticals Inc. (DFFN) is a Buy stock … The average price target is $3.50 with a high forecast of $3.50 and a low forecast of $3.50. DFFN | Complete Diffusion Pharmaceuticals Inc. stock news by MarketWatch. Diffusion Pharmaceuticals Inc. analyst estimates by MarketWatch.